Endpoints News 13 janv. 2026 FDA delays decision on expanding label for Travere's kidney disorder drug
Endpoints News 13 janv. 2026 Trump administration appears to have ended its US trade probe into pharma
Endpoints News 13 janv. 2026 VantAI gets $80M and new name; Dynavax discloses it had pre-Sanofi suitor
Endpoints News 13 janv. 2026 AbbVie reaches MFN deal with the White House, pledges billions to US manufacturing
Endpoints News 13 janv. 2026 Novartis licenses radiopharma asset from Chinese biotech for $50M upfront
Endpoints News 12 janv. 2026 #JPM26: Novo Nordisk CEO says pharma can learn from the GLP-1 compounding boom